Pediatric Challenges, Big and Small
Pediatric drug development is at a critical juncture with growing regulatory demands and trial recruitment challenges. But there is exciting innovation today and in our horizon that will help us get crucial medicines to children faster. We invite you to join thought leaders from academia, industry, and health authorities during our 2nd annual New Horizons in Pediatric Drug Development Symposium. Our 2-day virtual event will focus on innovations that can help advance your pediatric drug development program in oncology, rare and infectious diseases.
Featured Speakers
We are excited to feature discussions led by key thought leaders in pediatric drug development from industry, regulatory agencies, and academia.
Brian Aylward, MD
Chair European Medicines Agency Paediatric Committee
Neil Sebire, MB BS, BClinSci MD
Professor & Chief Research Information Officer Great Ormond Street Hospital
Annagrazia Altavilla, PhD, HDR
Lawyer, TEDDYNETWORK Chair, Espace Ethique Paca-Corse
Krithika Arun Shetty, PhD
Associate Director, Certara
Jeff Barrett, PhD
Chief Science Officer, Aridhia DRE
Elly Barry, MD, MMSc
Head of Clinical Development, Day One Biopharmaceuticals
Adrie Bekker, PhD, MD
Professor, Stellenbosch University
Samuel Blackman, PhD, MD
Founder & Chief Medical Officer Day One BIopharmaceuticals
Felix Boakye-Agyeman, PhD, MD
Senior Director of Pharmacometrics, Certara
Julie Bullock, PharmD
Senior Vice President, Global Head of Clinical Pharmacology & Translational Medicine, Certara
Arthur L. Caplan, PhD
Drs. William F and Virginia Connolly Mitty Chair Director, Division of Medical Ethics NYU Grossman School of Medicine
Amy Cheung, PhD
Senior Director of Integrated Drug Development, Certara
Glen Clack, MB, BS, MD, FFPM
Professor of Translational Medicine, University of Manchester
Solange Corriol-Rohou, MD
Sr. Director of Regulatory Affairs & Policy for Europe, AstraZeneca
Lynne Georgopoulos, RN, MSHS, RAC
Vice President, Regulatory Strategy, Certara
Rachel G. Greenberg, MD, MHS
Neonatologist and Associate Professor of Pediatrics at Duke University Medical Center
Angela James, PhD
Vice President, Head of Clinical Pharmacology, MacroGenics Inc.
Alice Ke, PhD
Senior Director, PBPK, Certara
Maryna Kolochavina, PharmD, PhD, PMP
Director, Five Voices Consortium
Kerry Jo Lee, MD
Associate Director for Rare Diseases, US FDA, CDER
Jian Li, PhD
Professor Monash University, Australia
Brian Maas, PharmD
Principal Scientist, Quantitative Pharmacology and Pharmacometrics
Dave Mitchell, PhD
Senior Vice President, Strategic Engagement, Certara
Flora Musuamba Tshinanu, PhD
Professor University of Namur
David Nobbs, PhD
International Regulatory Policy Lead for Digital Health and Data Policy, Roche
Robert Nelson, MD, PhD
Senior Director, Pediatric Drug Development Johnson & Johnson
Lauren Price, PharmD
Clinical Pharmacology Reviewer, US FDA, CDER
Leyla Sahin, MD
US FDA, Center for Drug Evaluation and Research
Virna Schuck, PhD
VP, Head of Clinical Pharmacology, Ribon Therapeutics
Joe Standing, PhD
Professor of Pharmacometrics Great Ormond Street Hospital for Children
Ashley Strougo, PhD
Childhood Cancer Program Lead, Sanofi
Isaac Rodriguez-Chavez, Ph.D., M.H.S., M.S.
SVP, Scientific & Clinical Affairs, Head, Center for DCTs & Digital Medicine, ICON plc
Karen Rowland Yeo, PhD
Senior Vice President of Client and Regulatory Strategy, Certara
Lionel Tan, MBBS, FRCP, PhD, DTM&H
ViiV Healthcare, Research and Development
John van den Anker, MD, PhD
Division Chief, Clinical Pharmacology, Children's National Hospital
Lynne Yao, MD
Director at Division of Pediatric and Maternal Health at US FDA, CDER